跳至主要内容
临床试验/ISRCTN49726849
ISRCTN49726849已完成1 期

Pharmacokinetics and Pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children

Imperial College, London0 个研究点目标入组 105 人开始时间: 2017年10月27日最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
105

研究概览

简要总结

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37519413/ (added 31/07/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children aged 6 months to 12 years at admission to hospital with Plasmodium falciparum malaria (on either blood film or ParacheckTM rapid diagnostic test)
  • 2. Axillary temperature >380C or <360C
  • 3. ‘Teule’ severity criteria: any one of the following: prostration; respiratory distress; severe anaemia (haemoglobin<5g/dL) or HIV infection
  • 4. Parents willing/able to provide consent

排除标准

  • 1. Major contraindications to azithromycin, eg strong existing clinical diagnosis of QT-prolongation
  • 2. Concomitant use of interacting drugs: drugs that may cause QT-prolongation or drugs that may cause a pharmacokinetic interaction with azithromycin, like strong CYP3A/P-GP inducers and concomitantly administered antacids

研究者

相似试验

The pharmacology of azithromycin in severe malaria... | 临床试验